Sanofi launches generic Arava through Winthrop

BRIDGEWATER, N.J. — Sanofi announced Thursday that it had launched its generic of Arava (lefluniomide) tablets through its U.S. generics division Winthrop.

Leflunomide is indicated to increase mobility among rheumatoid arthritis patients by reducing inflammation and will be available form Winthrop in 10- and 20-mg tablets.

“The Arava authorized generic assures patients that they receive the same quality treatment of the original drug,” Sanofi’s VP general therapeutics and life cycle management Dr. Cary Yonce said. “We are committed to making authorized generics like Arava available and affordable to patients who need them.”